[go: up one dir, main page]

EA200200776A1 - Этанольный сольват (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она - Google Patents

Этанольный сольват (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она

Info

Publication number
EA200200776A1
EA200200776A1 EA200200776A EA200200776A EA200200776A1 EA 200200776 A1 EA200200776 A1 EA 200200776A1 EA 200200776 A EA200200776 A EA 200200776A EA 200200776 A EA200200776 A EA 200200776A EA 200200776 A1 EA200200776 A1 EA 200200776A1
Authority
EA
Eurasian Patent Office
Prior art keywords
piperidinyl
cis
hydroxy
methyl
chlorophenil
Prior art date
Application number
EA200200776A
Other languages
English (en)
Other versions
EA005182B1 (ru
Inventor
Курт М. Кесселер
Original Assignee
Авентис Фармасьютикалз Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фармасьютикалз Инк. filed Critical Авентис Фармасьютикалз Инк.
Publication of EA200200776A1 publication Critical patent/EA200200776A1/ru
Publication of EA005182B1 publication Critical patent/EA005182B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Представлены этанольная сольватная форма (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4R-(3S-гидрокси-1-метил)пиперидинил]-4Н-1-бензопиран-4-она (форма II), способ получения формы II и композиция, содержащая форму II.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200776A 2000-01-18 2001-01-08 Этанольный сольват (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она EA005182B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48781500A 2000-01-18 2000-01-18
PCT/US2001/000520 WO2001053294A1 (en) 2000-01-18 2001-01-08 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one

Publications (2)

Publication Number Publication Date
EA200200776A1 true EA200200776A1 (ru) 2002-12-26
EA005182B1 EA005182B1 (ru) 2004-12-30

Family

ID=23937213

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200776A EA005182B1 (ru) 2000-01-18 2001-01-08 Этанольный сольват (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она

Country Status (26)

Country Link
EP (1) EP1252155B1 (ru)
JP (1) JP2003520798A (ru)
KR (1) KR100825530B1 (ru)
CN (1) CN1395577A (ru)
AR (1) AR027226A1 (ru)
AT (1) ATE284400T1 (ru)
AU (1) AU2001230869A1 (ru)
BR (1) BR0107724A (ru)
CA (1) CA2397594C (ru)
CZ (1) CZ301235B6 (ru)
DE (1) DE60107652T2 (ru)
DK (1) DK1252155T3 (ru)
EA (1) EA005182B1 (ru)
ES (1) ES2228800T3 (ru)
HU (1) HU225155B1 (ru)
IL (2) IL150643A0 (ru)
MX (1) MXPA02006965A (ru)
NO (1) NO322626B1 (ru)
NZ (1) NZ520281A (ru)
PL (1) PL201690B1 (ru)
PT (1) PT1252155E (ru)
SI (1) SI1252155T1 (ru)
SK (1) SK287216B6 (ru)
TW (1) TWI293072B (ru)
WO (1) WO2001053294A1 (ru)
ZA (1) ZA200205640B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2769251C2 (ru) 2016-08-23 2022-03-29 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Комбинированная терапия для лечения гепатоцеллюлярной карциномы
BR112019019261A2 (pt) 2017-03-16 2020-06-16 Eisai R & D Management Co., Ltd. Terapias de combinação para o tratamento de câncer de mama

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (ru) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
HUP0204297A2 (hu) 2003-04-28
DE60107652D1 (de) 2005-01-13
NO322626B1 (no) 2006-11-06
CN1395577A (zh) 2003-02-05
KR100825530B1 (ko) 2008-04-25
SK287216B6 (sk) 2010-03-08
NZ520281A (en) 2004-04-30
SK10372002A3 (sk) 2002-12-03
EA005182B1 (ru) 2004-12-30
IL150643A (en) 2009-08-03
PL201690B1 (pl) 2009-04-30
DE60107652T2 (de) 2005-12-22
ES2228800T3 (es) 2005-04-16
MXPA02006965A (es) 2004-09-06
PL355992A1 (en) 2004-05-31
CA2397594C (en) 2010-03-23
EP1252155B1 (en) 2004-12-08
TWI293072B (en) 2008-02-01
CA2397594A1 (en) 2001-07-26
WO2001053294A1 (en) 2001-07-26
AR027226A1 (es) 2003-03-19
DK1252155T3 (da) 2005-04-04
KR20020069514A (ko) 2002-09-04
SI1252155T1 (en) 2005-06-30
PT1252155E (pt) 2005-04-29
JP2003520798A (ja) 2003-07-08
CZ20022467A3 (cs) 2002-10-16
EP1252155A1 (en) 2002-10-30
NO20023385D0 (no) 2002-07-12
AU2001230869A1 (en) 2001-07-31
NO20023385L (no) 2002-08-27
IL150643A0 (en) 2003-02-12
HUP0204297A3 (en) 2005-04-28
ATE284400T1 (de) 2004-12-15
ZA200205640B (en) 2003-11-26
HU225155B1 (en) 2006-07-28
CZ301235B6 (cs) 2009-12-16
BR0107724A (pt) 2002-10-01

Similar Documents

Publication Publication Date Title
EA199700262A1 (ru) Способ получения 2-метилтиенобензодиазепина и его кристаллические формы
EA200300118A1 (ru) Тетрагидропиридино- или пиперидиногетероциклические производные
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
EA200501250A1 (ru) Композиция, содержащая смесь активных начал, и способ ее получения
BR9813022B1 (pt) derivados de ésteres hidroxiacéticos, seu processo de preparação e sua utilização como intermediários de sìntese.
BR9606821A (pt) Processo de racemização para uso na fabricação de levobupivacaina e agentes anestésicos correlacionados de piperidina carboxanilida
EA200501046A1 (ru) Эсциталопрамгидробромид и способ его получения
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
EA199900027A1 (ru) Способ получения некоторых азациклогексапептидов
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
EA200200776A1 (ru) Этанольный сольват (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она
ES2175899T3 (es) Procedimiento para la preparacion de derivados de piridindicarboxilato.
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
EA199900740A1 (ru) Способ получения эпросартана (варианты)
EA200001076A1 (ru) Способ получения 4-замещенных-1h-индол-3-глиоксамидов
EA200400876A1 (ru) Способ получения производных толуола
WO2002054043A3 (en) Method of searching for and generating high free energy forms
DE60104822D1 (de) Pseudopolymorph von (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-on hydrochlorid
EA199800029A1 (ru) СПОСОБ ПОЛУЧЕНИЯ БЕНЗО[b]ТИОФЕНОВ
EA200100864A1 (ru) Способ получения 1,4,7,10-тетраазациклододекана
EA200300249A1 (ru) Промежуточные соединения для использования при получении витамина e
EA200001212A1 (ru) Усовершенствованный способ получения производных норбензоморфана с ценными фармацевтическими свойствами
AU2002343178A1 (en) Method to query an embebbed database

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU